MINNEAPOLIS, March 29, 2016 -- 21st North Inc. (formerly known as Urologix, Inc.) announced today that its Special Meeting of Shareholders commenced earlier today was adjourned for lack of quorum and will be reconvened at 10:00 a.m. local time on April 25, 2016. The reconvened meeting will be held at 4200 IDS Center, 80 South 8th Street, Minneapolis, Minnesota 55402. Extending the voting until April 25th, 2016 provides additional time for shareholders to submit their proxy cards. Shareholders that have voted do not need to vote again.
The Special Meeting of Shareholders is for the purpose of approving the dissolution of 21st North Inc. pursuant to the Plan of Dissolution previously distributed to shareholders. 21st North Inc. has no assets, no operations and substantial liabilities in the form of debt owed to a secured creditor following surrender of the assets to its creditor and subsequent asset sale to a private buyer effective on January 29, 2016. There will be no shareholder distributions nor any transfer of value or liabilities to shareholders as a result of this transaction. Shareholder approval of the Plan of Dissolution will enable the company to terminate the legal existence of the shell in an orderly manner.
Contact Information: Greg Fluet [email protected]


Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 



